{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"","title":"the Refill: Pharmacy Burnout Crisis - Latest Data and What Comes Next","description":"

Welcome back to *The Refill*, your weekly dose of what’s new, what’s important, and what’s shaping the world of pharmacy and mental health. Today, we’re breaking down the top five stories from the past week—stories that matter for clinicians, caregivers, patients, and anyone who cares about the future of health. Let’s get into it.


Until next time… Remember to breathe. Carry what matters. Let go of the rest and stay Mindful.


References


https://timesofindia.indiatimes.com/city/mysuru/jss-college-to-host-international-conference-on-sustainable-brain-health/articleshow/125351837.cms

https://www.businessgrouphealth.org/newsroom/news-and-press-releases/press-releases/2025-employer-health-care-strategy-survey

https://arxiv.org/abs/2510.10364

https://news.ashp.org/News/ashp-news/2025/07/08/pharmacy-organizations-collaborate-to-prioritize-pharmacy-workforce-well-being-and-mental-health?utm_sourc

https://nabp.pharmacy/news/news-releases/pharmacy-organizations-collaborate-to-prioritize-pharmacy-workforce-well-being-and-mental-health/

https://www.neurologyadvisor.com/news/fda-greenlights-caplyta-for-adjunctive-use-in-mdd/

https://www.pharmacytimes.com/view/fda-approves-lumateperone-with-antidepressant-use-for-major-depressive-disorder

https://www.pharmacytimes.com/view/fda-approves-lumateperone-with-antidepressant-use-for-major-depressive-disorder


","author_name":"Dr. Matmon Harrell"}